
Increased use of fluoroquinolones has been associated with some decreased susceptibility to these agents among Streptococcus pneumoniae. Consider the potential for a further increase in the prevalence of antimicrobial resistance, as well as safety concerns in children, when prescribing fluoroquinolones.